HealthBank Holdings Limited (SGX:40B)
Singapore · Delayed Price · Currency is SGD 0.0550
+0.0050 (10.00%)
At close: Sep 3, 2026
HealthBank Holdings Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 6.28 | 1.68 | 1.33 | 1.04 | 2.74 | 7.91 |
Short-Term Investments | - | 0.03 | 0.03 | 0 | 0 | 0.04 |
Cash & Short-Term Investments | 6.28 | 1.7 | 1.36 | 1.04 | 2.74 | 7.95 |
Cash Growth | 377.57% | 25.50% | 30.86% | -62.13% | -65.55% | 537.45% |
Other Receivables | 0.03 | 0.05 | - | - | - | 0.02 |
Receivables | 0.03 | 0.05 | 1.09 | - | 9.51 | 0.02 |
Inventory | 3.34 | - | - | - | - | - |
Prepaid Expenses | 0.05 | 0.09 | 0.1 | 0.03 | 0.03 | 0.3 |
Total Current Assets | 9.7 | 1.84 | 2.55 | 1.07 | 12.28 | 8.27 |
Property, Plant & Equipment | 0 | - | - | 0 | 0.01 | 0.02 |
Long-Term Investments | 9 | 13.16 | 14.62 | 16.54 | 49.1 | 55.23 |
Total Assets | 18.7 | 15 | 17.17 | 25.38 | 61.39 | 73.01 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accrued Expenses | - | 0.54 | 0.62 | 0.99 | 1.17 | 0.76 |
Short-Term Debt | 2.04 | - | - | - | - | - |
Other Current Liabilities | 0.7 | 0.39 | 0.37 | 0.01 | 0.14 | 0.07 |
Total Current Liabilities | 2.74 | 0.93 | 0.99 | 1 | 1.31 | 0.83 |
Long-Term Debt | - | - | - | - | - | 9.13 |
Total Liabilities | 2.74 | 0.93 | 0.99 | 1 | 1.31 | 9.96 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 46.27 | 38.67 | 37.51 | 37.51 | 37.51 | 29.19 |
Retained Earnings | -34.87 | -29.47 | -26.23 | -18.06 | 17.96 | 28.37 |
Comprehensive Income & Other | 4.8 | 5.06 | 5.03 | 5.02 | 4.63 | 5.46 |
Total Common Equity | 16.2 | 14.26 | 16.31 | 24.47 | 60.1 | 63.02 |
Minority Interest | -0.24 | -0.19 | -0.13 | -0.08 | -0.02 | 0.03 |
Shareholders' Equity | 15.96 | 14.07 | 16.17 | 24.38 | 60.08 | 63.06 |
Total Liabilities & Equity | 18.7 | 15 | 17.17 | 25.38 | 61.39 | 73.01 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 2.04 | - | - | - | - | 9.13 |
Net Cash (Debt) | 4.24 | 1.7 | 1.36 | 1.04 | 2.74 | -1.18 |
Net Cash Growth | 222.36% | 25.50% | 30.86% | -62.13% | - | - |
Net Cash Per Share | 0.04 | 0.02 | 0.01 | 0.01 | 0.03 | -0.02 |
Filing Date Shares Outstanding | 141.15 | 109.8 | 94.3 | 94.3 | 94.3 | 78 |
Total Common Shares Outstanding | 141.15 | 102.05 | 94.3 | 94.3 | 94.3 | 78 |
Working Capital | 6.96 | 0.91 | 1.55 | 0.07 | 10.97 | 7.44 |
Book Value Per Share | 0.11 | 0.14 | 0.17 | 0.26 | 0.64 | 0.81 |
Tangible Book Value | 16.2 | 14.26 | 16.31 | 24.47 | 60.1 | 63.02 |
Tangible Book Value Per Share | 0.11 | 0.14 | 0.17 | 0.26 | 0.64 | 0.81 |
Machinery | - | - | - | 0.01 | 0.01 | 0.02 |